A randomized phase 2 study of maintenance pemetrexed versus docetaxel following pemetrexed plus carboplatin in advanced non-small cell lung cancer
Not Applicable
- Conditions
- advanced non-small cell lung cancer
- Registration Number
- JPRN-UMIN000004075
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criterias are as follows 1: Squamous cell carcinoma 2: Active interstitial pneumonia identified by chest X-ray 3: Uncontrolled massive pleural effusion or cardiac effusion 4: Superior vena cava syndrome 5: Uncontrolled brain metastases 6: Uncontrolled diabetes mellitus, hypertension, hepatic disorder, angina pectoris or previous myocardial infarction within the last 12 months 7: Severe infection 8: Pregnancy or lactation 9: Active concomitant malignancy 10: History of severe allergic reactions to drugs 11: Severe and unstable medical comorbidities 12: Judgment to attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method